- Home
- / Shukra Pharmaceuticals
Shukra Pharmaceuticals
Stock Price
₹67.6
2024-10-29
Market Capitalization
₹108.7 M
2024-10-29
Revenue
₹567.3 M
FY, 2026
Shukra Pharmaceuticals Summary
Company Summary
- Overview
- Shukra Pharmaceuticals is a company that develops and manufacture pharmaceutical products. It offers tablets, liquid injectables, and capsules. The company also provides contract manufacturing services.
- Type
- Public
- Status
- Active
- Founded
- 1993
- Cybersecurity rating
Table of Contents
Shukra Pharmaceuticals Financials
Summary Financials
- Revenue (FY, 2026)
- ₹567.3M
- Gross profit (FY, 2026)
- ₹454.6M
- Net income (FY, 2026)
- ₹220.6M
- Cash (FY, 2026)
- ₹59.8M
- EBIT (FY, 2026)
- ₹298.8M
- Enterprise value
- $99.2M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026